Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell LymphomaXinhua Wang, Mingzhi Zhang, Linan Zhu et al.|JAMA Oncology|2022Cited by 61
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective studyJingjing Wu, Mingzhi Zhang, Wenhua Wang et al.|Investigational New Drugs|2022Cited by 44
Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38MAPK pathwaysRui Lin, Mingzhi Zhang, Xiaoli Li et al.|Experimental Cell Research|2021Cited by 29
Human immunodeficiency virus-negative plasmablastic lymphomaLi Lin, Qingjiang Chen, Xudong Zhang et al.|Medicine|2017Cited by 18
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment FailureJunxia Hu, Qingjiang Chen, Xin Wang et al.|Frontiers in Oncology|2021Cited by 17